{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:59:31Z","timestamp":1776322771374,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biologicals.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:16:00Z","timestamp":1613560560000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccine"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-0221","authenticated-orcid":false,"given":"Nilgun","family":"Yakubogullari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furkan Ozan","family":"Coven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusin","family":"Cebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fethiye","family":"Coven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejdet","family":"Coven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-8776","authenticated-orcid":false,"given":"Rukan","family":"Genc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Nalbantsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2021.01.005_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jep.2007.05.020","article-title":"In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus","volume":"113","author":"Cho","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib2","first-page":"1965","volume":"vol. 1","author":"Ayta\u00e7","year":"2000"},{"key":"10.1016\/j.biologicals.2021.01.005_bib3","first-page":"834","article-title":"Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species","volume":"23","author":"Bedir","year":"2000","journal-title":"BiolPharmBull"},{"key":"10.1016\/j.biologicals.2021.01.005_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jep.2011.01.054","article-title":"Adjuvant effects of Astragalus saponins macrophyllosaponin B and astragaloside VII","volume":"134","author":"Nalbantsoy","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jep.2011.11.053","article-title":"Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species","volume":"139","author":"Nalbantsoy","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib6","first-page":"71","volume":"vol. 96","author":"Yesilada","year":"2005"},{"key":"10.1016\/j.biologicals.2021.01.005_bib7","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1016\/j.vaccine.2019.05.038","article-title":"Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS)","volume":"37","author":"Yakubo\u011fullar\u0131","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.005_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12010-014-1245-z","article-title":"Designing and modeling of complex DNA vaccine based on tropomyosin protein of boophilus genus tick","volume":"175","author":"Ranjbar","year":"2015","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib9","series-title":"Vaccine design","author":"Vogel","year":"1995"},{"key":"10.1016\/j.biologicals.2021.01.005_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotechnol Res Innov"},{"key":"10.1016\/j.biologicals.2021.01.005_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biologicals.2019.10.002","article-title":"Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice","volume":"62","author":"Maraghi","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2021.01.005_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00031","article-title":"The combination vaccine adjuvant system Alum\/c-di-AMP results in quantitative and qualitative enhanced immune responses post immunization","volume":"9","author":"Ebensen","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biologicals.2019.11.001","article-title":"A class \u2160 lentogenic newcastle disease virus strain confers effective protection against the prevalent strains","volume":"63","author":"yun","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2021.01.005_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7278459","article-title":"Diagnostic and vaccination approaches for newcastle disease virus in poultry: the current and emerging perspectives","volume":"2018","author":"Bello","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.biologicals.2021.01.005_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.provac.2013.06.006","article-title":"Reduction of newcastle disease vaccine dose using a novel adjuvant for cellular immune response in poultry","volume":"7","author":"Arous","year":"2013","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s12010-009-8838-y","article-title":"Hemolytic and antimicrobial activities differ among saponin-rich extracts from guar, quillaja, yucca, and soybean","volume":"162","author":"Hassan","year":"2010","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phymed.2017.10.019","article-title":"New perspectives for natural triterpene glycosides as potential adjuvants","volume":"37","author":"Lacaille-Dubois","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biologicals.2021.01.005_bib18","doi-asserted-by":"crossref","first-page":"152905","DOI":"10.1016\/j.phymed.2019.152905","article-title":"Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: a review","volume":"60","author":"Lacaille-Dubois","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biologicals.2021.01.005_bib19","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1021\/ja062364i","article-title":"Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi","volume":"128","author":"Kim","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biologicals.2021.01.005_bib20","doi-asserted-by":"crossref","first-page":"13448","DOI":"10.1021\/ja305121q","article-title":"Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes","volume":"134","author":"Chea","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biologicals.2021.01.005_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nchem.1963","article-title":"Development of a minimal saponin vaccine adjuvant based on QS-21","volume":"6","author":"Fern\u00e1ndez-Tejada","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.biologicals.2021.01.005_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the Adjuvant System story","volume":"13","author":"Gar\u00e7on","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2021.01.005_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/erv.11.18","article-title":"Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer","volume":"10","author":"Ragupathi","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2021.01.005_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/np980399t","article-title":"Secondary metabolites from the roots of Astragalus trojanus","volume":"62","author":"Bedir","year":"1999","journal-title":"J Nat Prod"},{"key":"10.1016\/j.biologicals.2021.01.005_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijbiomac.2013.12.002","article-title":"Structural features and biological activities of the polysaccharides from Astragalus membranaceus","volume":"64","author":"Jin","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijbiomac.2010.02.004","article-title":"Astragalus polysaccharide and oxymatrine can synergistically improve the immune efficacy of Newcastle disease vaccine in chicken","volume":"46","author":"Chen","year":"2010","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection","volume":"6","author":"O'Hagan","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2021.01.005_bib28","series-title":"Quila fraction with low toxicity and use thereof","author":"Morein","year":"2006"},{"key":"10.1016\/j.biologicals.2021.01.005_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4028\/www.scientific.net\/AMR.662.149","article-title":"Preparation and optimization of a Live Newcastle disease virus vaccine encapsulated in chitosan nanoparticles","volume":"662","author":"Hao","year":"2013","journal-title":"Adv Mater Res"},{"key":"10.1016\/j.biologicals.2021.01.005_bib30","first-page":"47","article-title":"Methods of blood collection in the mouse","volume":"29","author":"Hoff","year":"2000","journal-title":"Lab Anim"},{"key":"10.1016\/j.biologicals.2021.01.005_bib31","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1016\/j.vaccine.2015.07.016","article-title":"Adjuvant potential of resiquimod with inactivated Newcastle disease vaccine and its mechanism of action in chicken","volume":"33","author":"Sachan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.005_bib32","volume":"vol. 46","author":"Rehmani","year":"1995"},{"key":"10.1016\/j.biologicals.2021.01.005_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejps.2004.05.005","article-title":"Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity","volume":"22","author":"Homhuan","year":"2004","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.biologicals.2021.01.005_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijbiomac.2014.01.067","article-title":"The adjuvanticity of Ganoderma lucidum polysaccharide for Newcastle disease vaccine","volume":"65","author":"Zhang","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib35","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.intimp.2011.08.018","article-title":"Structure-function relationship of the saponins from the roots of Platycodon grandiflorum for hemolytic and adjuvant activity","volume":"11","author":"Sun","year":"2011","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.biologicals.2021.01.005_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vetimm.2009.04.009","article-title":"Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens","volume":"131","author":"Tseng","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051103","article-title":"Immunobiology of newcastle disease virus and its use for prophylactic vaccination in poultry and as adjuvant for therapeutic vaccination in cancer patients","volume":"18","author":"Schirrmacher","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biologicals.2021.01.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.biologicals.2021.01.005_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2004.06.010","article-title":"Overview of interleukin-2 function, production and clinical applications","volume":"28","author":"Gaffen","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.biologicals.2021.01.005_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3906\/vet-1207-30","article-title":"Enhancement of immune response for newcastle disease vaccine using a combined adjuvant solution of astragalus polysaccharides, levamisole, and selenoprotein","volume":"37","author":"Sun","year":"2013","journal-title":"Turk J Vet Anim Sci"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:40Z","timestamp":1760922880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105621000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"alternative-id":["S1045105621000208"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.01.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccine","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}